CompletedNCT00866645
Levosulpiride or haloperidol for agitation in schizophrenia
About this title
A Study To Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia
Read the official source — NCT00866645Researchers compared Intramuscular Levosulpiride and Intramuscular Haloperidol to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Medication studyAges 18–65China
Understand this study
What did researchers investigate?
Researchers compared Intramuscular Levosulpiride and Intramuscular Haloperidol to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Baoding and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateFebruary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 240
- Sponsor
- Shanghai Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- China
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00866645
- Official title
Show the full official title
A Randomized Blind Parallel Intramuscular Haloperidol-Controlled Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Intramuscular Levosulpiride in the Treatment of Chinese Patients With Agitation Of Schizophrenia
Get this study by email
Recruitment & locations
CompletedBaoding · Nanjing · Xi'an
2 more locations
- Shanghai
- Kunming
Questions about this study
What did researchers investigate?
Researchers compared Intramuscular Levosulpiride and Intramuscular Haloperidol to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Who is behind this study?
The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Intramuscular Haloperidol and Intramuscular Levosulpiride.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to explore more studies?
Explore studiesRelated studies
5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolarity